Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

  1. Lingvay, I.
  2. Harris, S.
  3. Jaeckel, E.
  4. Chandarana, K.
  5. Ranthe, M.F.
  6. Jódar, E.
Journal:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Year of publication: 2018

Volume: 20

Issue: 1

Pages: 200-205

Type: Article

DOI: 10.1111/DOM.13043 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus